Arismendi, E, Muñoz, M, Crespo, A, Ausin, P, Castillo, JA, Curto, E, Lapuente, A, Arguedas, AM, Martínez-Rivera, C, Monserrate, D, Muñoz, X, Ojanguren, I, Palones, E, Paredes, M, Pilia, F, Picado, C, Sabater, G, Sabadell, C, Sogo, A, Cañete, C. Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3926. PMID:. IF:21.000(Q1/1D).

Pinilla, L, Dodani, K, Benitez, I, Esmaeli, N, Gracia-Lavedán, E, Torres, G, Minguez, O, Martinez, D, Martínez-García, MA, Abad, J, Masdeu, MJ, Mediano, O, Muñoz, C, Cabriada, V, Duran-Cantolla, J, Mayos, M, Coloma, R, Montserrat, JM, De la Peña, M, Cano-Pumarega, I, Barbé, F, Azarbarzin, A, Sanchez-De-la-Torre, M. Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2693. PMID:. IF:21.000(Q1/1D).

Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Criée, CP, Trinkmann, F. Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2121. PMID:. IF:21.000(Q1/1D).

Greulich, T, Bogoevska, V, Nachtigall, D, Russell, R, Suppli, C, Wolfgang, U, Pohl, W, Plaza, V, Bourdin, A, Baumeister, S, Gessner, C. Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3907. PMID:. IF:21.000(Q1/1D).